Inventor · disambiguated record
Robert Charles Glen
Also filed as: GLEN ROBERT · GLEN ROBERT C · GLEN ROBERT CHARLES
10 granted patents·2 pending applications·708 citations·filing 1991–2019
92Inventor score
Files withARENA PHARM INC3BURROUGHS WELLCOME CO2GLAXO WELLCOME INC2CAMBRIDGE ENTPR LTD1CONOPCO INC DBA UNILEVER1
Top patents by PatentIndex Score
12 records- 0197US6140509ANon-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereofARENA PHARM INC·Filed 1999·Granted Oct 31, 2000·180 cites·1 claims
- 0296US6150393ASmall molecule modulators of non-endogenous, constitutively activated human serotonin receptorsARENA PHARM INC·Filed 1999·Granted Nov 21, 2000·136 cites·12 claims
- 0394US6107324A5-HT2A receptor inverse agonistsARENA PHARM INC·Filed 1999·Granted Aug 22, 2000·179 cites·7 claims
- 0492US5399574AIndolyl tetrahydropyridines for treating migraineBURROUGHS WELLCOME CO·Filed 1991·Granted Mar 21, 1995·103 cites·5 claims
- 0590US5466699AIndolyl compounds for treating migraineBURROUGHS WELLCOME CO·Filed 1994·Granted Nov 14, 1995·76 cites·11 claims
- 0674US5863935ATherapeutic heterocyclic compoundsZENECA LTD·Filed 1995·Granted Jan 26, 1999·30 cites·9 claims
- 0766US11976137B2Compounds for use as apelin receptor antagonistsCAMBRIDGE ENTPR LTD·Filed 2019·Granted May 7, 2024·1 cites·10 claims
- 0853US2016243015A1Skin lightening compositionCONOPCO INC DBA UNILEVER·Filed 2014·Application pending·0 cites
- 0936US5744466ATherapeutic heterocyclic compoundsWELLCOME FOUND·Filed 1995·Granted Apr 28, 1998·2 cites·7 claims
- 1034US6103752ATherapeutic heterocyclic compoundsGLAXO WELLCOME INC·Filed 1999·Granted Aug 15, 2000·1 cites·8 claims
- 1130US5922748AIndole derivatives as 5-HT agonistsGLAXO WELLCOME INC·Filed 1998·Granted Jul 13, 1999·0 cites·11 claims
- 1229US2013053372A15-ht receptor modulatorsKAPADNIS PRASHANT BHIMRAO·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Charles Glen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →